Akèy › Melanom
Etid klinik pou Melanom ap rekrite nan Etazini
197 etid pou Melanom ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX59 etid
- New York City, NY38 etid
- Los Angeles, CA34 etid
- Nashville, TN32 etid
- Pittsburgh, PA31 etid
- Boston, MA25 etid
- Philadelphia, PA23 etid
- San Francisco, CA22 etid
- Atlanta, GA21 etid
- Columbus, OH21 etid
- Salt Lake City, UT21 etid
- Durham, NC21 etid
- Arlington, VA20 etid
- Dallas, TX20 etid
- St. Louis, MO20 etid
- Tampa, FL19 etid
- Denver, CO19 etid
- Aurora, CO18 etid
- San Diego, CA18 etid
- Washington, DC17 etid
- Grand Rapids, MI17 etid
- Seattle, WA17 etid
- Cincinnati, OH17 etid
- Rochester, MN16 etid
- Jacksonville, FL16 etid
- Queens, NY16 etid
- Edison, NJ16 etid
- Portland, OR15 etid
- Chicago, IL15 etid
- San Antonio, TX15 etid
- Orlando, FL15 etid
- Madison, WI15 etid
- Orange, CA14 etid
- Cleveland, OH13 etid
- Omaha, NE12 etid
- Ann Arbor, MI12 etid
- Minneapolis, MN12 etid
- Detroit, MI11 etid
- Baltimore, MD11 etid
- Birmingham, AL11 etid
Pa eta
- Alabama12 etid
- Alaska5 etid
- Arizona26 etid
- Arkansas13 etid
- Ayiti3 etid
- Colorado32 etid
- Connecticut14 etid
- Delaware6 etid
- Distrik Columbia7 etid
- Florid55 etid
- Georgia23 etid
- Idaho8 etid
- Illinois22 etid
- Indiana14 etid
- Iowa12 etid
- Kalifòni70 etid
- Kansas15 etid
- Kentucky21 etid
- Lwizyàn9 etid
- Main4 etid
- Maryland24 etid
- Massachusetts28 etid
- Michigan31 etid
- Minnesota29 etid
- Mississippi3 etid
- Missouri22 etid
- Montana8 etid
- Nebraska16 etid
- Nevada6 etid
- New Hampshire6 etid
- New Jersey24 etid
- New Mexico11 etid
- New York50 etid
- North Carolina31 etid
- North Dakota9 etid
- Ohio40 etid
- Oklahoma14 etid
- Oregon15 etid
- Pennsylvania47 etid
- Rhode Island5 etid
- South Carolina10 etid
- South Dakota6 etid
- Tennessee39 etid
- Texas77 etid
- Utah26 etid
- Vermont5 etid
- Virginia34 etid
- Washington25 etid
- West Virginia7 etid
- Wisconsin20 etid
- Wyoming3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07740941Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07281924A Study of BI 3810944 in Patients With Advanced Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07224425A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06961006Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07519655Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks – 99 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT00040352DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06246916A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06172478Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06548789A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Ap rekriteFaz 2
Jiska laj 25 · Tout sèks · Mizajou Sep 24, 2026 · NCT07621614Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT05727904Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379Pan-tumor MRD Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Ap rekriteFaz 3
Laj 75 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07068074Intratumoral N17350 in Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07339176Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07661966Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT06814496A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT06066138A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07830225Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06529822Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05267626BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04752826Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.